| Typicality: | 0.447 |
| Saliency: | 0.385 |
| often | 3 | temporal |
| between 2002 | 2 | temporal |
| trial → be sponsored by → the national cancer institute | 19 |
| trial → be funded by → the national cancer institute | 11 |
| trial → be funded by → the u.s. national cancer institute | 3 |
| negative | neutral | positive |
| 0.116 | 0.831 | 0.053 |
| Raw frequency | 33 |
| Normalized frequency | 0.385 |
| Modifier score | 0.600 |
| Perplexity | 17.901 |